Literature DB >> 11161802

Human eIF5A2 on chromosome 3q25-q27 is a phylogenetically conserved vertebrate variant of eukaryotic translation initiation factor 5A with tissue-specific expression.

Z A Jenkins1, P G Hååg, H E Johansson.   

Abstract

Eukaryotic translation initiation factor 5A (eIF5A) is an essential protein tightly linked to cellular polyamine homeostasis. It receives the unique spermidine-derived posttranslational modification hypusine that is necessary for eIF5A's biochemical activity and cellular proliferation. The eIF5A protein stimulates ribosomal peptidyl-transferase and may be involved in nucleocytoplasmic mRNA transport. Little is known about the molecular genetics of eIF5A. Here we report on the sequence and molecular characterization of human EIF5A2, a novel phylogenetically conserved gene for eIF5A. EIF5A2 stretches over 17 kb and consists of five exons and four introns. It is localized at 3q25-q27, often noted for chromosomal instability in cancers. EIF5A2 is highly expressed in testis and colorectal adenocarcinoma and at moderate levels in the brain, in contrast to the ubiquitously expressed EIF5A1 gene. Two EIF5A2 mRNAs share a 129-nt 5' UTR and a coding sequence for the 153-amino-acid eIF5AII protein, but possess two alternative 3' UTRs of 46 and 890 nt that arise through differential polyadenylation. The protein is 84% identical and 94% similar to eIF5AI. Both EIF5A genes are conserved in vertebrates. Our findings lend further support for a specialized gene expression program of polyamine metabolic proteins and regulators that function to maintain polyamine homeostasis at elevated levels during spermatogenesis. Copyright 2001 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11161802     DOI: 10.1006/geno.2000.6418

Source DB:  PubMed          Journal:  Genomics        ISSN: 0888-7543            Impact factor:   5.736


  49 in total

1.  The unique hypusine modification of eIF5A promotes islet beta cell inflammation and dysfunction in mice.

Authors:  Bernhard Maier; Takeshi Ogihara; Anthony P Trace; Sarah A Tersey; Reiesha D Robbins; Swarup K Chakrabarti; Craig S Nunemaker; Natalie D Stull; Catherine A Taylor; John E Thompson; Richard S Dondero; Eli C Lewis; Charles A Dinarello; Jerry L Nadler; Raghavendra G Mirmira
Journal:  J Clin Invest       Date:  2010-05-24       Impact factor: 14.808

Review 2.  Translational control in cancer.

Authors:  Deborah Silvera; Silvia C Formenti; Robert J Schneider
Journal:  Nat Rev Cancer       Date:  2010-04       Impact factor: 60.716

3.  Biological Relevance and Therapeutic Potential of the Hypusine Modification System.

Authors:  Nora Pällmann; Melanie Braig; Henning Sievert; Michael Preukschas; Irm Hermans-Borgmeyer; Michaela Schweizer; Claus Henning Nagel; Melanie Neumann; Peter Wild; Eugenia Haralambieva; Christian Hagel; Carsten Bokemeyer; Joachim Hauber; Stefan Balabanov
Journal:  J Biol Chem       Date:  2015-06-02       Impact factor: 5.157

Review 4.  The translation factor eIF5A and human cancer.

Authors:  Michael B Mathews; John W B Hershey
Journal:  Biochim Biophys Acta       Date:  2015-05-13

5.  Effectiveness of gene expression profiling for response prediction of rectal cancer to preoperative radiotherapy.

Authors:  Eiki Ojima; Yasuhiro Inoue; Chikao Miki; Masaki Mori; Masato Kusunoki
Journal:  J Gastroenterol       Date:  2007-09-25       Impact factor: 7.527

6.  Knockdown of EIF5A2 inhibits the malignant potential of non-small cell lung cancer cells.

Authors:  Cheng Chen; Bojia Zhang; Shanshan Wu; Yongxiang Song; Jian Li
Journal:  Oncol Lett       Date:  2018-01-22       Impact factor: 2.967

Review 7.  Posttranslational synthesis of hypusine: evolutionary progression and specificity of the hypusine modification.

Authors:  E C Wolff; K R Kang; Y S Kim; M H Park
Journal:  Amino Acids       Date:  2007-05-04       Impact factor: 3.520

8.  Phosphorylation of maize eukaryotic translation initiation factor 5A (eIF5A) by casein kinase 2: identification of phosphorylated residue and influence on intracellular localization of eIF5A.

Authors:  Maja Łebska; Arkadiusz Ciesielski; Lidia Szymona; Luiza Godecka; Elzbieta Lewandowska-Gnatowska; Jadwiga Szczegielniak; Grazyna Muszynska
Journal:  J Biol Chem       Date:  2009-12-15       Impact factor: 5.157

9.  Expression of eukaryotic translation initiation factor 5A-2 (eIF5A-2) associated with poor survival in gastric cancer.

Authors:  Qiong Yang; Zaiyuan Ye; Qi Zhang; Zhongsheng Zhao; Hongjun Yuan
Journal:  Tumour Biol       Date:  2015-08-18

10.  Inhibition of HIV-1 gene expression by Ciclopirox and Deferiprone, drugs that prevent hypusination of eukaryotic initiation factor 5A.

Authors:  Mainul Hoque; Hartmut M Hanauske-Abel; Paul Palumbo; Deepti Saxena; Darlene D'Alliessi Gandolfi; Myung Hee Park; Tsafi Pe'ery; Michael B Mathews
Journal:  Retrovirology       Date:  2009-10-13       Impact factor: 4.602

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.